Treatment of inflammatory bowel disease: a comprehensive review
Z Cai, S Wang, J Li - Frontiers in medicine, 2021 - frontiersin.org
Inflammatory bowel disease (IBD), as a global disease, has attracted much research
interest. Constant research has led to a better understanding of the disease condition and …
interest. Constant research has led to a better understanding of the disease condition and …
Ulcerative colitis in adults: A review
Importance Ulcerative colitis (UC) is a chronic inflammatory condition of the colon, with a
prevalence exceeding 400 per 100 000 in North America. Individuals with UC have a lower …
prevalence exceeding 400 per 100 000 in North America. Individuals with UC have a lower …
ECCO guidelines on therapeutics in ulcerative colitis: medical treatment
Ulcerative colitis [UC] is a chronic inflammatory bowel disease [IBD] characterised by colonic
inflammation extending to a variable extent from the rectum. Care of the patient with UC …
inflammation extending to a variable extent from the rectum. Care of the patient with UC …
Selecting therapeutic targets in inflammatory bowel disease (STRIDE): determining therapeutic goals for treat-to-target
OBJECTIVES: The Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE)
program was initiated by the International Organization for the Study of Inflammatory Bowel …
program was initiated by the International Organization for the Study of Inflammatory Bowel …
Efficacy and safety of biologics and small molecule drugs for patients with moderate-to-severe ulcerative colitis: a systematic review and network meta-analysis
Background There is a growing armamentarium for the treatment of moderate-to-severe
ulcerative colitis. We aimed to compare the relative efficacy and safety of biologics and small …
ulcerative colitis. We aimed to compare the relative efficacy and safety of biologics and small …
Vedolizumab as induction and maintenance therapy for ulcerative colitis
BG Feagan, P Rutgeerts, BE Sands… - … England Journal of …, 2013 - Mass Medical Soc
Background Gut-selective blockade of lymphocyte trafficking by vedolizumab may constitute
effective treatment for ulcerative colitis. Methods We conducted two integrated randomized …
effective treatment for ulcerative colitis. Methods We conducted two integrated randomized …
Third European evidence-based consensus on diagnosis and management of ulcerative colitis. Part 2: current management
M Harbord, R Eliakim, D Bettenworth… - Journal of Crohn's …, 2017 - academic.oup.com
11.1. General The treatment strategy for ulcerative colitis [UC] is mainly based on the
severity, distribution [proctitis, left-sided, extensive] 1 and pattern of disease. The latter …
severity, distribution [proctitis, left-sided, extensive] 1 and pattern of disease. The latter …
Current and emerging therapeutic targets for IBD
MF Neurath - Nature Reviews Gastroenterology & Hepatology, 2017 - nature.com
Various therapeutic advances have led to a paradigm shift in the clinical management of
patients with IBD. The introduction of immunosuppressive (such as azathioprine) and …
patients with IBD. The introduction of immunosuppressive (such as azathioprine) and …
[HTML][HTML] Ulcerative colitis—diagnostic and therapeutic algorithms
T Kucharzik, S Koletzko, K Kannengiesser… - Deutsches Ärzteblatt …, 2020 - ncbi.nlm.nih.gov
Background Ulcerative colitis is a chronic inflammatory bowel disease with an estimated 150
000 patients in Germany alone. Methods This review is based on publications about current …
000 patients in Germany alone. Methods This review is based on publications about current …
First-and second-line pharmacotherapies for patients with moderate to severely active ulcerative colitis: an updated network meta-analysis
Background & Aims We compared the efficacy and safety of different first-line (biologic-
naïve) and second-line (prior exposure to tumor necrosis factor [TNF] antagonists) agents for …
naïve) and second-line (prior exposure to tumor necrosis factor [TNF] antagonists) agents for …